Introduction
Because myocardial ischemia is a leading cause of death in the western world, clinical application to treat ischemic diseases such as myocardial infarction, arrhythmia, and angina, has attracted considerable attention. 1 Administration of sodium hydrogen exchanger type 1 (NHE-1) inhibitors reduced infarct size, myocardial stunning, arrhythmia, and endothelial dysfunction caused by ischemia/reperfusion injury in various pre-clinical works, which indicates the potential of NHE-1 inhibitors to treat ischemic diseases. [2] [3] [4] Most known NHE-1 inhibitors have an acylguanidine functionality as key pharmacophore. 5 However, there are concerns on the acylguanidine group which has the possibility to release guanidine under metabolic conditions, a known cause of toxicity. Then efforts to discover non-acylguanidine NHE-1 inhibitors have been made, 6 and several compounds containing imidazole as an acylguanidine surrogate group have been reported. 7, 8 We previously found the potent acylguanidine NHE-1 inhibitors with furan 9 or benzothiophene 10 core template, and attempted to replace the acylguanidine group with imidazole ( Figure 1 ). This paper describes the synthesis, and biological evaluation of 4-heteroaryl-2-amino-5-methylimidazole derivatives, and compared with the corresponding acylguanidine compounds. Starting from the benzothiophene-2-carboxylic acids (19 and 20), the 4-(benzothiophen-2-yl)-2-amino-5-methylimidazoles (21 and 22) were prepared according to the same procedure with the furan derivatives (Scheme 2).
Biological Evaluation
The NHE-1 inhibitory activities of the synthesized compounds were determined by measuring their ability to inhibit NHE-1 mediated recovery of intracellular pH following an imposed acidosis in PS120 variant cells selectively expressing the human NHE-1. 15 Using this method the IC50 value for cariporide, known NHE-1 inhibitor, was measured as 1.0 µM.
Results and Discussion
The inhibitory effects of synthesized compounds on NHE-1 were determined as IC50. Previously studied acylguanidines were comparable to or much more potent than cariporide. Especially the 2-methoxy-5-chlorophenyl furan compound 33 (IC 50 = 0.06 µM) was 10 times more potent than cariporide on NHE-1, and also showed excellent cardioprotective efficacy in both in vitro function assay and in vivo ischemia animal model. 9 2-Amino-4-methylimidazole derivatives (16-18, 29
and 30) were as active as the corresponding acylguanidines, which indicates that the 2-amino-4-methylimidazole moiety can be an acylguanidine surrogate. We will continue the study on this series of compounds including function assay, in vivo animal model, pharmacokinetic and toxicological properties to identify an effective and safe anti-ischemic agent.
Experimental Section
Chemistry. Melting points were determined on a capillary melting point apparatus and are uncorrected. Anhydrous solvents were dried by conventional methods. Reagents of commercial quality were used from freshly opened containers unless otherwise stated. 
1-[5-(3-Fluorophenyl)furan-2-yl]propan-1-one (7):
A solution of 4 (1.7 g, 6.9 mmol) in THF (18 mL) was cooled to 78 o C, and ethylmagnesium bromide (2 M in THF, 17.3 mL) was slowly added during 1 h with stirring. After the completion of reaction, water (20 mL) was added, and the mixture was extracted with ethyl acetate (60 mL) twice. The organic layer was washed with brine, dried (MgSO 4 ), filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane:ethyl acetate = 10:1) to yield 7 as an oil (1.03 g, 68%). The compound 13 (160 mg, 0.53 mmol) was dissolved in methanol (3 mL), and 8 N HCl (1.5 mL) was added. The reaction mixture was heated at reflux with stirring for 4 hr, and cooled to rt, following the basification with 6 N NaOH to pH 10, and extraction with ethyl acetate (30 mL) twice. The organic layer was washed brine, dried (MgSO4), filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (20% methanol in CH2Cl2), which was dissolved in acetone (4 mL), treated with methanesulfonic acid with stirring, and cooled to 0 o C. The resulting precipitates were filtered to yield 16 as a pale brown solid. (38.5 mg, 21%). -exchanger (NHE-1) inhibitory activity was used as our primary screen and measured by the rate of NHE-1 mediated recovery of intracellular pH (pHi) in a 96-well microplate using a pH sensitive fluorescent dye, 2',7'-bis-2-carboxyethyl-5-(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM, Sigma-Aldrich Co., MO, USA).
23,24 PS120 Fibroblast cells expressing human NHE-1 were obtained from Professor J. Pouyssegur (Nice, France), 20 and maintained in Dulbecco's modified Eagle's medium (DM-EM) supplemented with 1% penicillin/ streptomycin (100X solution), 1% L-glutamine (200 mM solution), and 10% fetal bovine serum at 37 ºC, in humidified atmosphere of 5% CO2 and 95% air. Cells were grown to confluency and then harvested from 100 mm Culture dishes using Trypsin-EDTA solution. Cells were washed twice with Na-free buffer (138.2 mM choline chloride, 4.9 mM KCl, 1.5 mM CaCl2.2H2O, 1.2 mM Mg-SO4·7H2O, 1.2 mM KH2PO4, 15 mM D-glucose, 20 mM HEP-ES, at pH 7.4) and incubated with 10 µM of BCECF-AM and 20 mM NH4Cl at 37 ºC for 30 min. The BCECF-and NH4Cl-loaded cells were then washed, resuspended in Na-free buffer, and kept on ice.
The 10 µL of the BCECF-and acid-loaded cells (2.5 × 10 4 cells) was added to 180 µL of HBS buffer containing NaCl (137 mM NaCl, 4.9 mM KCl, 1.5 mM CaCl2.2H2O, 1.2 mM MgSO4·7H2O, 1.2 mM KH2PO4, 15 mM D-glucose, 20 mM HEPES, pH 7.4) with 10 µL of DMSO or compounds in 96-well microplate. NHE activity was initiated by NaCl, and fluorescence readings were taken 4 min after the addition of acidified cell to each microplate containing NaCl, at 444 nm excitation/ 535 nm emission and also at 485 nm excitation/535 nm emission using a spectrofluorometer (GEMINI-XS, Molecular Device, CA, USA) at room temperature. Activity in the absence of NaCl was subtracted from the activity in the presence of NaCl. The initial increase in pHi in response to NaCl was taken as an estimate of Na + /H + -exchange activity, and the inhibitory effect of the compounds was evaluated as IC50 value (concentration required to inhibit pHi recovery by 50%). Calibration of pHi was accomplished using the high K + -nigericin method. 25 The BC-ECF fluorescence ratio (485/444) was plotted against pHi and fitted by linear regression.
